Clinical trial
Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's…
NCT00315250 · Institute for Neurodegenerative Disorders, Other · Completed
Key facts
| NCT number | NCT00315250 |
|---|---|
| Title | Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease |
| Official title | Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease |
| Lead sponsor | Institute for Neurodegenerative Disorders, Other |
| Collaborators | United States Department of Defense U.S. Fed Molecular NeuroImaging |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson's Disease, Parkinsonian Syndrome |
| Intervention type | Drug |
| Interventions | [123I]β-CIT |
| Enrollment | 225 |
| Start date | Jan 1, 2006 |
| Primary completion | Jan 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Apr 18, 2006 |
| Last update posted | May 9, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: